论文部分内容阅读
目的:观察速避凝治疗老年人急性脑梗死的疗效及安全性。方法:对90例发病在48小时内的老年人急性脑梗死患者随机分为治疗组与对照组,分别给予这避凝及普通治疗。结果:治疗组与对照组治愈率有显著差异(P<0.05),总有效率有极显著差异(P<0.01)。结论:速避凝为新一代抗栓药,具有疗效好及副作用少等优点,对老年人脑梗死疗效肯定,应用方便,值得在临床推广应用。
OBJECTIVE: To observe the efficacy and safety of speed-avoiding coagulation in the treatment of acute cerebral infarction in the elderly. Methods: Ninety patients with acute cerebral infarction within 48 hours were randomly divided into treatment group and control group. Results: The cure rate of the treatment group and the control group were significantly different (P <0.05), the total effective rate was significantly different (P <0.01). Conclusion: Avoidance of antithrombotic drug is a new generation of antithrombotic drugs. It has the advantages of good curative effect and less side effects. It is effective in the treatment of cerebral infarction in the elderly and has the advantages of convenient application and worthy of clinical application.